Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.
about
Relative importance of rotavirus-specific effector and memory B cells in protection against challenge.Immune responses to rotavirus infection and vaccination and associated correlates of protectionAntirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea.Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells.Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particlesSerotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.Characterization of homologous and heterologous rotavirus-specific T-cell responses in infant and adult mice.Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections.Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge.Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles.Protective immunity to rotavirus shedding in the absence of interleukin-6: Th1 cells and immunoglobulin A develop normallySerum IgG mediates mucosal immunity against rotavirus infectionGroup A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infectionRectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation.Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmissionMice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidatesA gastrointestinal rotavirus infection mouse model for immune modulation studies.Active viremia in rotavirus-infected mice.Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina.Immune mediators of rotavirus antigenemia clearance in mice.Development of mucosal and systemic lymphoproliferative responses and protective immunity to human group A rotaviruses in a gnotobiotic pig modelCross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entryMagnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protectionMucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virusRole of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice.Circulating immunoglobulin G can play a critical role in clearance of intestinal reovirus infection.Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.Effects of the route of infection on immunoglobulin G subclasses and specificity of the reovirus-specific humoral immune response.Identification of a T-helper cell epitope on the rotavirus VP6 protein.Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon.Rotavirus virus-like particles administered mucosally induce protective immunity.Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activitiesDistinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus InfectionsThe intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells.Treatment of rotaviral gastroenteritis with Qiwei Baizhu powder.Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice.
P2860
Q24531443-336E0CC7-3FE4-4597-9829-8417DE0CE60CQ24626023-DE42C00C-3B89-4A2E-8A97-6C6F7B9AE683Q32077043-144AD0F1-613C-4195-9F00-5FAA8D1F2AD8Q33289420-DBDEC23A-8451-4500-A459-0092DD925467Q33352435-8369A29E-DCE4-4CB5-9D68-5BBD17C2BFBEQ33604018-85E350C9-BC0F-4179-BB1E-7CF04E3CF601Q33649920-8AFAC688-BF52-4B40-9E28-6E24011232FAQ33654939-F005EA1E-955B-40F3-9C65-8AFA39405BBAQ33724357-284AFDD5-28A9-4105-B6F1-DF36AC7F421CQ33782483-2A39D5BB-85A0-4FB5-8970-5596AB57BA22Q33783470-EACD3049-C4BA-439F-83E2-283B64A1BCF3Q33785598-7129B234-782E-4AA9-A103-7CC4E966E926Q33787123-A7881C1B-FF3B-4498-A97D-0DBC1CDB87BAQ33821665-5834C963-0DEE-4709-8356-45E0FFA448E0Q34326366-93B272D3-DB0E-4787-B291-17F0B76B4292Q34353344-3FBBBC3E-8E88-4892-904E-010718D9CD1CQ34437155-A1B61766-C746-44A8-BF9C-A16F537EC307Q34545989-AF1F532D-6E98-460E-A7C4-969DFE417639Q34647668-FB9841D1-0000-4C0D-9E25-367686E49B1DQ34704839-BDDAA4B1-2251-479E-8645-51CB47028AD3Q34716764-23B17491-C51C-4864-99AD-DFF75AD6A6ECQ34791255-5E57737F-E5F2-4B72-AE45-E6FBF49BA10DQ35019757-80293E19-AF1B-4DC1-93B9-204781BC8A09Q35140279-96F32FC5-CA7B-4FAA-ACD8-FA9F89C462F5Q35226896-373B7050-BAB0-4BCF-AA69-64CB2AC9B510Q35275131-8B9D35BA-BB83-4EB0-B51B-5130A7932121Q35542518-563AE329-B2A2-4D2A-AC0F-3C89CC43FC6EQ35849627-20F42606-54F8-41EB-B8DA-ADE610E20C9DQ35852251-915C560C-A621-4BE5-8B3C-F3EC3906AB0FQ35854941-18FEFEDB-8DB0-444A-A03C-EEC3EA5BC6D4Q35860373-06D6674C-945B-4CD2-88AF-A92F9F619412Q35867962-437148A3-597A-4CE8-913F-563A0DC81C49Q35874990-F359550A-5C9B-4A33-A3CC-4579DCF20454Q35875143-3EEDE96B-0B20-4E9E-9107-2AD12002AB31Q35898882-E320703D-3D56-448E-9A3D-AF87EA28E187Q35898922-0D2650A8-5897-4178-918C-4A7F5398AC68Q36003428-1B1FA0B5-BBBF-4AA6-8077-7E8AC1D21E3FQ36369860-89236DE6-1B63-4092-BA5B-25D56F87701EQ36415666-DFE89AA5-1EA9-43BA-81E8-278FECB1DABEQ36535017-5777340F-C698-4775-BF0B-CBB550F86D82
P2860
Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Comparison of mucosal and syst ...... s or a heterologous rotavirus.
@ast
Comparison of mucosal and syst ...... s or a heterologous rotavirus.
@en
type
label
Comparison of mucosal and syst ...... s or a heterologous rotavirus.
@ast
Comparison of mucosal and syst ...... s or a heterologous rotavirus.
@en
prefLabel
Comparison of mucosal and syst ...... s or a heterologous rotavirus.
@ast
Comparison of mucosal and syst ...... s or a heterologous rotavirus.
@en
P2093
P2860
P1433
P1476
Comparison of mucosal and syst ...... us or a heterologous rotavirus
@en
P2093
P2860
P304
P407
P577
1994-12-01T00:00:00Z